Paul Ingravallo

2.9k total citations
30 papers, 1.6k citations indexed

About

Paul Ingravallo is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Paul Ingravallo has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 14 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in Paul Ingravallo's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (11 papers) and HIV/AIDS drug development and treatment (11 papers). Paul Ingravallo is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (11 papers) and HIV/AIDS drug development and treatment (11 papers). Paul Ingravallo collaborates with scholars based in United States, Brazil and United Kingdom. Paul Ingravallo's co-authors include John W. Barnwell, Mary R. Galinski, Masanori Aikawa, Julian C. Rayner, M. Yamaya, Ralph L. Nachman, Adam S. Asch, Francine B. Perler, Ernest Asante‐Appiah and Frederick Lahser and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Paul Ingravallo

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Ingravallo United States 20 1.0k 529 377 347 243 30 1.6k
Francis Fumoux France 20 525 0.5× 500 0.9× 463 1.2× 189 0.5× 197 0.8× 48 1.4k
Nicola K. Viebig Germany 14 585 0.6× 514 1.0× 266 0.7× 74 0.2× 191 0.8× 23 1.2k
Benoît Gamain France 26 2.0k 1.9× 1.1k 2.1× 201 0.5× 143 0.4× 395 1.6× 72 2.3k
Christian Roussilhon France 21 1.3k 1.2× 658 1.2× 210 0.6× 58 0.2× 286 1.2× 46 1.6k
Robert Schwenk United States 19 1.0k 1.0× 717 1.4× 331 0.9× 48 0.1× 473 1.9× 26 1.6k
Mafalda Resende Denmark 19 893 0.9× 547 1.0× 142 0.4× 134 0.4× 335 1.4× 29 1.3k
Christine Langer Australia 20 1.3k 1.3× 630 1.2× 191 0.5× 45 0.1× 346 1.4× 32 1.7k
Bruno Pouvelle France 17 1.6k 1.6× 915 1.7× 174 0.5× 64 0.2× 310 1.3× 27 1.9k
Ronald Perraut Senegal 21 885 0.9× 531 1.0× 173 0.5× 44 0.1× 282 1.2× 82 1.4k
Claire Hutchings United Kingdom 17 261 0.3× 361 0.7× 262 0.7× 85 0.2× 271 1.1× 28 905

Countries citing papers authored by Paul Ingravallo

Since Specialization
Citations

This map shows the geographic impact of Paul Ingravallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Ingravallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Ingravallo more than expected).

Fields of papers citing papers by Paul Ingravallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Ingravallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Ingravallo. The network helps show where Paul Ingravallo may publish in the future.

Co-authorship network of co-authors of Paul Ingravallo

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Ingravallo. A scholar is included among the top collaborators of Paul Ingravallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Ingravallo. Paul Ingravallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonsall, David, Stuart Black, Anita Y. M. Howe, et al.. (2018). Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse. Infection and Drug Resistance. Volume 11. 1119–1135. 7 indexed citations
2.
Zhou, Shuntai, David R. McGivern, Christina L. Burch, et al.. (2018). Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus. Antiviral Research. 158. 45–51. 4 indexed citations
3.
Guo, Zhuyan, Stuart Black, Yuan Hu, et al.. (2017). Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a. Journal of Biological Chemistry. 292(15). 6202–6212. 8 indexed citations
4.
Zhang, Nanjing, Anthony Turpoff, Xiaoyan Zhang, et al.. (2015). Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B. Bioorganic & Medicinal Chemistry Letters. 26(2). 594–601. 10 indexed citations
5.
McGivern, David R., Takahiro Masaki, Paul Ingravallo, et al.. (2014). Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors. Gastroenterology. 147(2). 453–462.e7. 84 indexed citations
6.
Kong, Rong, Paul Ingravallo, Ying Zhai, et al.. (2012). 858 IN VITRO RESISTANCE ANALYSIS OF HCV NS5A INHIBITOR: MK-8742 DEMONSTRATES INCREASED POTENCY AGAINST CLINICAL RESISTANCE VARIANTS AND HIGHER RESISITANCE BARRIER. Journal of Hepatology. 56. S334–S335. 9 indexed citations
7.
Kong, Rong, et al.. (2010). A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. Antiviral Research. 86(2). 172–179. 22 indexed citations
8.
Hou, Yan, Andrew Prongay, Boris Feld, et al.. (2008). Screening for Antiviral Inhibitors of the HIV Integrase–LEDGF/p75 Interaction Using the AlphaScreen™ Luminescent Proximity Assay. SLAS DISCOVERY. 13(5). 406–414. 40 indexed citations
9.
Liu, Rong, Karim Abid, John Pichardo, et al.. (2006). In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease. Journal of Antimicrobial Chemotherapy. 59(1). 51–58. 13 indexed citations
10.
Rayner, Julian C., et al.. (2004). Plasmodium vivax merozoite surface protein PvMSP-3β is radically polymorphic through mutation and large insertions and deletions. Infection Genetics and Evolution. 4(4). 309–319. 48 indexed citations
11.
Barnwell, John W., et al.. (2002). Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum☆. Molecular and Biochemical Parasitology. 120(1). 41–52. 47 indexed citations
12.
Rayner, Julian C., et al.. (2002). Extensive polymorphism in the Plasmodium vivax merozoite surface coat protein MSP-3α is limited to specific domains. Parasitology. 125(5). 393–405. 69 indexed citations
13.
Ingravallo, Paul, Frederick Lahser, Ellen Xia, et al.. (2001). Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase. Virus Research. 75(2). 179–187. 4 indexed citations
14.
Galinski, Mary R., et al.. (2001). Plasmodium vivax merozoite surface proteins-3β and-3γ share structural similarities with P. vivax merozoite surface protein-3α and define a new gene family. Molecular and Biochemical Parasitology. 115(1). 41–53. 56 indexed citations
15.
Butkiewicz, Nancy, Nanhua Yao, Weidong Zhong, et al.. (2000). Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3. Journal of Virology. 74(9). 4291–4301. 36 indexed citations
16.
Barnwell, John W., Mary R. Galinski, Salvatore G. De-Simone, Francine B. Perler, & Paul Ingravallo. (1999). Plasmodium vivax, P. cynomolgi, andP. knowlesi:Identification of Homologue Proteins Associated with the Surface of Merozoites. Experimental Parasitology. 91(3). 238–249. 49 indexed citations
17.
Galinski, Mary R., et al.. (1999). Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain. Molecular and Biochemical Parasitology. 101(1-2). 131–147. 91 indexed citations
18.
Galinski, Mary R., et al.. (1992). A reticulocyte-binding protein complex of plasmodium vivax merozoites. Cell. 69(7). 1213–1226. 297 indexed citations
19.
20.
Barnwell, John W., Adam S. Asch, Ralph L. Nachman, et al.. (1989). A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes.. Journal of Clinical Investigation. 84(3). 765–772. 314 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Fumoux Breakdown of academic impact, for papers by Nicola K. Viebig Breakdown of academic impact, for papers by Benoît Gamain Breakdown of academic impact, for papers by Christian Roussilhon Breakdown of academic impact, for papers by Robert Schwenk Breakdown of academic impact, for papers by Mafalda Resende Breakdown of academic impact, for papers by Christine Langer Breakdown of academic impact, for papers by Bruno Pouvelle Breakdown of academic impact, for papers by Ronald Perraut Breakdown of academic impact, for papers by Claire Hutchings
Rankless by CCL
2026